This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Syn Ese Jolidon: Innovator in Malaria Treatment
Introduction
Syn Ese Jolidon is a notable inventor based in Blauen, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of malaria. His innovative approach focuses on combating chloroquine-resistant malaria, a growing concern in global health.
Latest Patents
Jolidon holds a patent for a method of treating chloroquine-resistant malaria with aminoquinoline. This patent describes novel aminoquinoline derivatives of a specific general formula. The methods outlined in his patent are aimed at treating malaria pathogens, especially those resistant to chloroquine, using compounds of the specified formula or their pharmaceutically acceptable salts and hydrolyzable esters.
Career Highlights
Syn Ese Jolidon is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has been instrumental in advancing treatments for malaria, showcasing his dedication to improving public health outcomes.
Collaborations
Throughout his career, Jolidon has collaborated with esteemed colleagues such as Werner Hofheinz and Catherine Jaquet. These partnerships have contributed to the development of innovative solutions in the fight against malaria.
Conclusion
Syn Ese Jolidon is a pioneering inventor whose work in malaria treatment exemplifies the importance of innovation in addressing global health challenges. His contributions continue to impact the medical field positively.